Wolverine Trading, LLC Volitionrx LTD Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.5 - $0.76 $2,300 - $3,496	4,600 Added 28.75%	20,600 $12,000
Q2 2024 Aug 14, 2024	BUY	$0.59 - $0.91 $531 - $819	900 Added 5.96%	16,000 $9,000
Q1 2024 May 15, 2024	BUY	$0.72 - $1.19 $2,880 - $4,760	4,000 Added 36.04%	15,100 $11,000
Q4 2023 Feb 14, 2024	BUY	$0.55 - $0.88 $6,105 - $9,768	11,100 New	11,100 $7,000
Q2 2023 Aug 23, 2023	BUY	$1.39 - $2.02 $13,065 - $18,988	9,400 Added 46.77%	29,500 $41,000
Q1 2023 May 15, 2023	SELL	$1.54 - $2.68 $770 - $1,340	-500 Reduced 2.43%	20,100 $39,000
Q4 2022 Feb 14, 2023	SELL	$1.39 - $2.6 $1,945 - $3,640	-1,400 Reduced 6.36%	20,600 $50,000
Q3 2022 Nov 14, 2022	BUY	$1.36 - $2.38 $29,920 - $52,360	22,000 New	22,000 $32,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $45.3M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.